Anifera

Recent Finacing

Seed

Recent Raise

Undisclosed

Anifera develops small-molecule adjunct therapies that increase bacterial susceptibility to existing antibiotics to potentiate treatments for animal infections, focusing initially on improving cure rates in bovine mastitis.